Curcumin analogues with high activity for inhibiting human prostate cancer cell growth and androgen receptor activation

Molecular Medicine Reports

Volumn 10, Issue 3, 2014, Pages 1315-1322

  Zhou, Dai Ying ^a,b,c   Ding, Ning ^c   Du, Zhi Yun ^a   Cui, Xiao Xing ^c   Wang, Hong ^c   Wei, Xing Chuan ^a   Conney, Allan H ^a,c   Zhang, Kun ^a   Zheng, Xi ^a,c  

^a GUANGDONG UNIVERSITY OF TECHNOLOGY   (China)

^b GUANGDONG FOOD AND DRUG VOCATIONAL COLLEGE   (China)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

Androgen receptor; Curcumin analogues; Prostate cancer; Prostate specific antigen

Indexed keywords

1,5 BIS(3,4,5 TRIMETHOXYPHENYL)PENTA 1,4 DIEN 3 ONE; 2,5 BIS(3,4,5 TRIMETHOXY BENZYLIDENE)CYCLOHEXANONE; 2,6 BIS(3,4,5 TRIMETHOXY BENZYLIDENE)CYCLOHEXANONE; 3,5 BIS(3,4,5 TRIMETHOXY BENZYLIDENE)TETRAHYDROPYRAN 4 ONE; 3,5 BIS(3,4,5 TRIMETHOXY BENZYLIDENE)TETRAHYDROTHIOPYRAN 4 ONE; ANDROGEN RECEPTOR; ANDROSTANOLONE; ANTINEOPLASTIC AGENT; CURCUMIN; TESTOSTERONE; UNCLASSIFIED DRUG; AR PROTEIN, HUMAN; PROSTATE SPECIFIC ANTIGEN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IC 50; LNCAP CELL LINE; LUCIFERASE ASSAY; MALE; PROSTATE CANCER; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; GENETICS; METABOLISM; PROSTATE TUMOR; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CURCUMIN; DIHYDROTESTOSTERONE; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION; TESTOSTERONE;

EID: 84905450778     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2380     Document Type: Article

References (37)

1. Siegel R, Ward E, Brawley O and Jemal A: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61:212-236, 2011.
2. Gao W, Bohl CE and Dalton JT: Chemistry and structural biology of androgen receptor. Chem Rev 105: 3352-3370, 2005. (Pubitemid 41430813)
3. Heinlein CA and Chang C: Androgen receptor in prostate cancer. Endocr Rev 25: 276-308, 2004. (Pubitemid 38501396)
4. Klotz L: Hormone therapy for patients with prostate carcinoma. Cancer 88 (Suppl): 3009-3014, 2000.
5. Simmons MN, Klein EA: Combined androgen blockade revisited: Emerging options for the treatment of castration-resistant prostate cancer. Urology 73: 697-705, 2009.
6. Kuttan R, Bhanumathy P, Nirmala K, et al: Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett 29: 197-202, 1985. (Pubitemid 16175818)
7. Huang MT, Smart RC, Wong CQ, et al: Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 48: 5941-5946, 1988. (Pubitemid 18266780)
8. Huang MT, Wang ZY, Georgiadis CA, et al: Inhibitory effects of curcumin on tumor initiation by benzo[a]pyrene and 7, 12-dimethylbenz[a]anthracene. Carcinogenesis 13: 2183-2186, 1992.
9. Huang MT, Lou YR, Ma W, et al: Inhibitory effects of dietary curcumin on forestomach duodenal, and colon carcinogenesis in mice. Cancer Res 54: 5841-5847, 1994. (Pubitemid 24375217)
10. Rao CV, Rivenson A, Simi B, et al: Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res 55: 259-266, 1995.
11. Leite KR, Chade DC, Sanudo A, et al: Effects of curcumin in an orthotopic murine bladder tumor model. Int Braz J Urol 35: 599-606, 2009.
12. Agrawal DK and Mishra PK: Curcumin and its analogues: potential anticancer agents. Med Res Rev 30: 818-860, 2010.
13. Kunnumakkara AB, Anand P and Aggarwal BB: Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269: 199-225, 2008.
14. Teiten MH, Gaascht F, Eifes S, et al: Chemopreventive potential of curcumin in prostate cancer. Genes Nutr 5: 61-74, 2010.
15. Bill MA, Bakan C, Benson DM Jr, et al: Curcumin induces proapoptotic effects against human melanoma cells and modulates the cellular response to immunotherapeutic cytokines. Mol Cancer Ther 8: 2726-2735, 2009.
16. Johnson SM, Gulhati P, Arrieta I, et al: Curcumin inhibits proliferation of colorectal carcinoma by modulating Akt/mTOR signaling. Anticancer Res 29: 3185-3190, 2009.
17. Piantino CB, Salvadori FA, Ayres PP, et al: An evaluation of the anti-neoplastic activity of curcumin in prostate cancer cell lines. Int Braz J Urol 35: 354-360, 2009.
18. Kuo CT, Chen BC, Yu CC, et al: Apoptosis signal-regulating kinase 1 mediates denbinobin-induced apoptosis in human lung adenocarcinoma cells. J Biomed Sci 16: 43, 2009.
19. Sahu RP, Batra S, Srivastava SK: Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells. Br J Cancer 100: 1425-1433, 2009.
20. Thangapazham RL, Sharma A and Maheshwari RK: Multiple molecular targets in cancer chemoprevention by curcumin. AAPS J 8: E443-E449, 2006. (Pubitemid 44096605)
21. Anand P, Sundaram C, Jhurani S, et al: Curcumin and cancer: an 'old-age' disease with an 'age-old' solution. Cancer Lett 267: 133-164, 2008.
22. Dhillon N, Aggarwal BB, Newman RA, et al: Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 14: 4491-4499, 2008.
23. Cheng AL, Hsu CH, Lin JK, et al: Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21: 2895-2900, 2001. (Pubitemid 33051148)
24. Wei X, Du ZY, Zheng X, et al: Synthesis and evaluation of curcumin-related compounds for anticancer activity. Eur J Med Chem 53: 235-245, 2012.
25. Zheng X, Chang RL, Cui XX, et al: Inhibitory effect of 12-O-tetradecanoylphorbol-13-acetate alone or in combination with all-trans-retinoic acid on the growth of LNCaP prostate tumors in immunodeficient mice. Cancer Res 64: 1811-1820, 2004. (Pubitemid 38428706)
26. Aggarwal BB: Prostate cancer and curcumin: add spice to your life. Cancer Biol Ther 7: 1436-1440, 2008.
27. Nakamura K, Yasunaga Y, Segawa T, et al: Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines. Int J Oncol 21: 825-830, 2002.
28. Tsui KH, Feng TH, Lin CM, et al: Curcumin blocks the activation of androgen and interlukin-6 on prostate specific antigen expression in human prostatic carcinoma cells. J Androl 29: 661-668, 2008.
29. Anand P, Kunnumakkara AB, Newman RA, et al: Bioavailability of curcumin: Problems and promises. Mol Pharm 4: 807-818, 2007.
30. Adams BK, Ferstl EM, Davis MC, et al: Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and antiangiogenesis agents. Bioorg Med Chem 12: 3871-3883, 2004. (Pubitemid 38798249)
31. Basile V, Ferrari E, Lazzari S, et al: Curcumin derivatives: molecular basis of their anti-cancer activity. Biochem Pharmacol 78: 1305-1315, 2009.
32. Ishida J, Ohtsu H, Tachibana Y, et al: Antitumor agents. Part 214: synthesis and evaluation of curcumin analogues as cytotoxic agents. Bioorg Med Chem 10: 3481-3487, 2002.
33. Ohori H, Yamakoshi H, Tomizawa M, et al: Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer. Mol Cancer Ther 5: 2563-2571, 2006. (Pubitemid 44650921)
34. Zhou J, Geng G, Shi Q, et al: Design and synthesis of androgen receptor antagonists with bulky side chains for overcoming antiandrogen resistance. J Med Chem 52: 5546-5550, 2009.
35. Shi Q, Shih CC, Lee KH: Novel anti-prostate cancer curcumin analogues that enhance androgen receptor degradation activity. Anticancer Agents Med Chem 9: 904-912, 2009.
36. Zsila F, Bikadi Z and Simonyi M: Circular dichroism spectroscopic studies reveal pH dependent binding of curcumin in the minor groove of natural and synthetic nucleic acids. Org Biomol Chem 2: 2902-2910, 2004.
37. Caruso F, Rossi M, Benson A, et al: Ruthenium-arene complexes of curcumin: X-ray and density functional theory structure, synthesis, and spectroscopic characterization, in vitro antitumor activity, and DNA docking studies of (p-Cymene) Ru (curcuminato) chloro. J Med Chem 55: 1072-1081, 2012.